Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

UCB INC

  • FDA Approval
  • Nov. 03, 2025, 17:15 UTC
  • 36
  • 0 comments

FDA approve DOXECITINE;DOXRIBTIMINE

Comment Full text

BIOMARIN PHARM

  • FDA Approval
  • Oct. 31, 2025, 18:23 UTC
  • 51
  • 0 comments

FDA approve ELOSULFASE ALFA

Comment Full text

AMNEAL IRELAND LIMITED

  • FDA Approval
  • Oct. 31, 2025, 14:39 UTC
  • 37
  • 0 comments

FDA approve BECLOMETHASONE DIPROPIONATE

Comment Full text

SANDOZ INC

  • FDA Approval
  • Oct. 31, 2025, 08:50 UTC
  • 36
  • 0 comments

FDA approve NATALIZUMAB-SZTN

Comment Full text

AMNEAL

  • FDA Approval
  • Oct. 31, 2025, 08:50 UTC
  • 36
  • 0 comments

FDA approve HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Comment Full text

PH HEALTH

  • FDA Approval
  • Oct. 31, 2025, 08:50 UTC
  • 39
  • 0 comments

FDA approve KETAMINE HYDROCHLORIDE

Comment Full text

SHANGHAI HENLIUS BIOTECH

  • FDA Approval
  • Oct. 30, 2025, 08:45 UTC
  • 34
  • 0 comments

FDA approve DENOSUMAB-NXXP

Comment Full text

NOVAST LABS

  • FDA Approval
  • Oct. 30, 2025, 08:45 UTC
  • 36
  • 0 comments

FDA approve DROSPIRENONE; ESTRADIOL

Comment Full text

MICRO LABS

  • FDA Approval
  • Oct. 30, 2025, 08:45 UTC
  • 35
  • 0 comments

FDA approve VARENICLINE TARTRATE

Comment Full text

MSN

  • FDA Approval
  • Oct. 30, 2025, 08:45 UTC
  • 43
  • 0 comments

FDA approve TICAGRELOR

Comment Full text
  • Previous
  • 65
  • 66
  • 67
  • 68
  • 69
  • Next

Search

News categories

  • Technical Exchange News(11292)
  • Event(2648)
  • SEC News(200042)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(132204)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin